Dergiler / European Oral Research / 2013 / Cilt: 47 - Sayı: 2

TÜKÜRÜK BİYOMARKERLARIN ERKEN TANIDAKİ ROLÜ-The Role of Salivary Biomarkers in Early Diagnostics

-

Sayfa
73–80
Yayın Tarihi
2013-07-29
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This article presents an overview of salivary biomarkers for oral cancers, sistemic infections and peridontal diseases.Keywords: Biomarkers, saliva, early detection of disease

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:ÖZErken tanı, başarılı bir tedavide önemli rol oynar.
📊
Temel Bulgular & Veri:Birçok vakada, hastalığın erken tanısı ile başarılı bir tedavi ya da kontrol gerçekleştirilebilmektedir.
💡
Sonuç & Katkı:This article presents an overview of salivary biomarkers for oral cancers, sistemic infections and peridontal diseases.Keywords: Biomarkers, saliva, early detection of disease
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Biyomarker · tükürük · erken tanı

Özet

ÖZErken tanı, başarılı bir tedavide önemli rol oynar. Birçok vakada, hastalığın erken tanısı ile başarılı bir tedavi ya da kontrol gerçekleştirilebilmektedir. Tükürük tanı yöntemleri, hastalık tanısında kolay, ucuz, güvenilir ve invazif olmayan uygulamaları içermektedir. Bu makale, ağız kanserleri, sistemik enfeksiyonlar, periodontal hastalık tanısında kullanılan tükürük biyomarkerlarına ilişkin genel bilgi içermektedir.Anahtar kelimeler: Biyomarker, tükürük, erken tanıABSTRACTEarly detection of disease plays a crucial role in successful therapy. In most cases, the earlier the disease is diagnosed, the more likely it is to be successfully cured or well controlled. Salivary diagnostics offer an easy, inexpensive, safe and non-invasive approach for disease detection. This article presents an overview of salivary biomarkers for oral cancers, sistemic infections and peridontal diseases.Keywords: Biomarkers, saliva, early detection of disease

Abstract

Early detection of disease plays a crucial role in successful therapy. In most cases, the earlier the disease is diagnosed, the more likely it is to be successfully cured or well controlled. Salivary diagnostics offer an easy, inexpensive, safe and non-invasive approach for disease detection. This article presents an overview of salivary biomarkers for oral cancers, sistemic infections and peridontal diseases.

🔖

Bu Makaleye Atıf Yap

ARAZ, M., GÜVEN, Y., AKTÖREN, O. (2013). TÜKÜRÜK BİYOMARKERLARIN ERKEN TANIDAKİ ROLÜ-The Role of Salivary Biomarkers in Early Diagnostics. European Oral Research, Cilt: 47 - Sayı: 2, 73–80. https://ajindex.com/articles/243395

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Marieb EN, Hoehn K. Human anatomy and physiology. 8th ed., San Francisco: Benjamin Cummings, 2009.
  2. Miller CS, Foley JD, Bailey AL, Campell CL, Humphries RL, Christodoulides N, Floriano PN, Simmons G, Bhagwandin B, Jacobson JW, Redding SW, Ebersole JL, McDevitt JT. Current developments in salivary diagnostics. Biomark Med, 2010; 4(1): 171 Lee YH, Wong DT. Saliva: an emerging biofluid for early detection of diseases. Am J Dent, 2009; 22(4): 241-48.
  3. Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers: a new diagnostic tool for oral cancer. Clin Cancer Res, 2006; 12(13): 3979–84. Sidransky D. Nucleic acid-based methods for the detection of cancer. Sciences, 1997; 278(5340): 1054–59.
  4. Tavassoli M, Brunel N, Maher R, Johnson NW, Soussi, T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer, 1998; 78(3): 390–91.
  5. Wagner P, Verma M, Srivastava S. Challenges for biomarkers in cancer detection. Ann NY Acad Sci, 2004; 1022: 9-16.
  6. Wong LJ, Lueth M, Li XN, Lau CC, Vogel H. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res, 2003; 63(14): 3866–71. Kocík M, Vymetalová Y, Málek I. Cellfree human DNA in body fluids-potential for clinical applications. Cas Lek Cesk, 2007; 146(2): 96–101.
  7. Schrohl AS, Würtz S, Kohn E, Banks RE, Nielsen HJ, Sweep FC, Brünner N. Banking of biological fluids for studies of disease-associated protein biomarkers. Mol Cell Proteomics, 2008; 7(10): 2061–66.
  8. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst, 2000; 92(9): 709–20.
  9. Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst, 2003; 95(23): 1772–83.
  10. Farnaud SJ, Kosti O, Getting SJ, Renshaw D. Saliva: physiology and diagnostics potential in health and disease. Scientific World Journal, 2010; 10: 434-56.
  11. Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer, 2004; 108(5): 766–72.
  12. Eguchi J, Ishihara